Philip J. Vickers
Chair, Science & Technology
Philip J. Vickers, Ph.D. has served as a director since February 2015. Dr. Vickers has spent more than 25 years in the pharmaceutical industry and is currently the President and Chief Executive Officer and a member of the board directors of Faze Medicines. Prior, he was the Chief Executive Officer and board member at Northern Biologics Inc., a developer of first-in-class immuno-oncology products. From 2011 to 2017 he served as Global Head of Research and Development at Shire, where he was responsible for overseeing preclinical research, clinical development, regulatory affairs, and medical affairs. Dr. Vickers was also a member of Shire’s Executive Committee and chaired the companies Pipeline Committee. Prior to Shire, he was Chief Scientific Officer and President at Resolvyx Pharmaceuticals, a biopharmaceutical company, from 2009 to 2011, where he was a member of the board of directors. He previously served in various capacities with international biopharmaceutical company’s including Boehringer-Ingelheim, Pfizer and Merck. Dr. Vickers was a Visiting Fellow at the National Cancer Institute in Bethesda, Maryland and holds a Ph.D. in Biochemistry from the University of Toronto, as well as a B.Sc. in Applied Biochemistry from the University of Salford, Manchester.